Citations

Clear

959 citation(s) found for "Service, F J".

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis
Valent, Peter , Escribano, Luís, Broesby‐Olsen, Sigurd , Hartmann, Karin , Grattan, Clive , Niedoszytko, Marek , Nedoszytko, Bogusław , Elberink, J. N. G. Oude, Kristensen, Thomas Kielsgaard , Butterfield, Joseph H. , Triggiani, Massimo , Álvarez‐Twöse, Iván , Reiter, Andreas , Sperr, Wolfgang R. , Sotlar, Karl , Yavuz, Selim , Kluin‐Nelemans, Hanneke C. , Hermine, Olivier , Radia, Deepti , Doormaal, J. J. van, Orfao, A., Siebenhaar, Frank , Schwartz, Lawrence B. , Maurer, Marcus , Horny, H.‐P., Akin, Cem , Metcalfe, Dean D. , Arock, Michel , Brockow, Knut , Gotlib, Jason , Orfao, A., Castells, Mariana , Sperr, Wolfgang , Valent, Peter , Hermine, Olivier , Akin, Cem , Arock, Michel , Kluin-Nelemans, Hanneke C

Mayo Clinic

Allergy | May 19, 2014 | Volume: 69 | Issue: 10 | Pages: 1267-1274

10.1111/all.12436 | PMID 24836395 Get It

AbstractMastocytosis is an emerging differential diagnosis in patients with more or less specific mediator‐related symptoms. In some of these patients, typical skin lesions are found and the diagnosis of mastocytosis can be established. In other cases, however, skin lesions are absent, which represents a diagnostic challenge. In the light of this unmet need, we developed a diagnostic algorithm for patients with suspected mastocytosis. In adult patients with typical lesions of mastocytosis in the skin, a bone marrow (BM) biopsy should be considered, regardless of the basal serum tryptase concentration. In adults without skin lesions who suffer from mediator‐related or other typical symptoms, the basal tryptase level is an important parameter. In those with a slightly increased tryptase level, additional investigations, including a sensitive KIT mutation analysis of blood leucocytes or measurement of urinary histamine metabolites, may be helpful. In adult patients in whom (i) KIT D816V is detected and/or (ii) the basal serum tryptase level is clearly increased (>25–30 ng/ml) and/or (iii) other clinical or laboratory features suggest the presence of ‘occult’ mastocytosis or another haematologic neoplasm, a BM investigation is recommended. In the absence of KIT D816V and other signs or symptoms of mastocytosis or another haematopoietic disease, no BM investigation is required, but the clinical course and tryptase levels are monitored in the follow‐up. In paediatric patients, a BM investigation is usually not required, even if the tryptase level is increased. Although validation is required, it can be expected that the algorithm proposed herein will facilitate the management of patients with suspected mastocytosis and help avoid unnecessary referrals and investigations.
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: An analysis of the SYNTAX Study
Bourantas, Christos V. , Zhang, Yao‐Jun , Garg, Scot , Mack, Michael J. , Dawkins, Keith D., Mohr, Friedrich W., Colombo, Antonio , Holmes, David R. , Ståhle, Elisabeth , Feldman, Ted , Morice, Marie‐Claude, Vries, Ton de, Morel, Marie‐Angèle , Kappetein, A. Pieter , Serruys, Patrick W. , Garg, Scot

Mayo Clinic

Catheterization and Cardiovascular Interventions | May 14, 2014 | Volume: 85 | Issue: 2 | Pages: 199-206

10.1002/ccd.25545 | PMID 24824456 Get It

ObjectivesTo investigate the prognostic implications of the presence of severe lesion calcification in patients undergoing coronary artery bypass graft (CABG) operation.BackgroundThere is robust evidence that lesion calcification is a predictor of worse prognosis in patients undergoing percutaneous coronary intervention; however, there is limited data about the prognostic implication of lesion calcium in patients treated with CABG.MethodsWe retrospectively analyzed data from 1,545 patients who underwent CABG and were recruited in the SYNTAX study and CABG registry. Two experts reviewed the angiographic data and classified patients in two groups: those with severely calcified coronary arteries and those without severe lesion calcification. Clinical outcomes at 5‐year follow‐up were collected and compared in the two groups.ResultsOne out of three patients exhibited severe lesion calcification (n = 588). Patients with calcified coronaries had an increased mortality at 5‐year follow‐up (17.1% vs. 9.9%, P < 0.001) and a higher event rate of death‐myocardial infarction (MI) compared with those without (19.4% vs. 13.2%, P = 0.003), but there was no statistical significant difference between the two groups for major adverse cardiovascular events (MACE, 26.8% vs. 21.8%, P = 0.057). In multivariate Cox regression analysis severe lesion calcification was an independent predictor of an increased all‐cause mortality (hazard ratio: 1.39, 95% confidence interval: 1.02–1.89; P = 0.037) but it was not an independent predictor of the combined end‐points death‐MI or MACE.ConclusionsSevere lesion calcification is associated with an increased mortality in patients undergoing CABG, but it is not an independent predictor of death‐MI or MACE. This paradox can be attributed to the fact that CABG allows perfusion of the healthy coronaries bypassing the diseased arteries and thus it minimizes the risk of coronary events due to progressive atherosclerosis. © 2014 Wiley Periodicals, Inc.
Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis
Ryan, Caitriona , Kelleher, John F., Fagan, M. F., Collins, Paul M. , Barker, Juliet N. , Allen, Michael , Hagan, Richard , Renfro, Lindsay A. , Rogers, Simon Neave , Kirby, Brian

Mayo Clinic

Clinical and Experimental Dermatology | April 23, 2014 | Volume: 39 | Issue: 4 | Pages: 519-524

10.1111/ced.12323 | PMID 24758522 Get It

Response to Letter Regarding Article, “Quantification of Incomplete Revascularization and Its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial: Validation of the Re
Farooq, Vasim , Bourantas, Christos V. , Zhang, Yao‐Jun , Muramatsu, Takashi , Feldman, Ted , Holmes, David R. , Mack, Michael J. , Morice, Marie Claude, Ståhle, Elisabeth , Colombo, Antonio , Vries, Ton de, Morel, Marie-angèle , Dawkins, Keith D., Mohr, Friedrich W., Serruys, Patrick W. , Morice, Marie‐Claude, Kappetein, A. Pieter

Mayo Clinic

Circulation | February 24, 2014 | Volume: 129 | Issue: 8 | Pages: No page available

10.1161/circulationaha.114.008026 | PMID 24566072 Get It

Increasing LH Pulsatility in Women With Hypothalamic Amenorrhoea Using Intravenous Infusion of Kisspeptin-54
Jayasena, Channa , Abbara, Ali , Veldhuis, Johannes D. , Comninos, Alexander , Ratnasabapathy, Risheka , Silva, Akila De, Nijher, Gurjinder, Ganiyu‐Dada, Zainab, Mehta, Amrish, Todd, Catriona, Ghatei, Mohammad A., Bloom, Stephen R. , Dhillo, Waljit S. , Jayasena, Channa N, Jayasena, Channa N

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | February 11, 2014 | Volume: 99 | Issue: 6 | Pages: E953-E961

10.1210/jc.2013-1569 | PMID 24517142 Get It

Improving Service Quality in Primary Care
Kennedy, Denise M. , Nordrum, Jon T., Edwards, Frederick , Caselli, Richard J., Edwards, Frederick D, Caselli, Richard J. , Berry, Leonard L.

Mayo Clinic

American Journal of Medical Quality | January 14, 2014 | Volume: 30 | Issue: 1 | Pages: 45-51

10.1177/1062860613518093 | PMID 24418754 Get It

Population-Based Study of Severe Hypoglycemia Requiring Emergency Medical Service Assistance Reveals Unique Findings
Parsaik, Ajay K. , Carter, Rickey E. , Pattan, Vishwanath , Kumar, Hamit, Smith, Steven A., Russi, Christopher S. , Levine, James A. , Basu, Ananda , Kudva, Yogish C. , Myers, Lucas A. , Carter, Rickey E

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 6 | Issue: 1 | Pages: 65-73

10.1177/193229681200600109 | PMID 22401324 Get It

Objective: The objective is to report a contemporary population-based estimate of hypoglycemia requiring emergency medical services (EMS), its burden on medical resources, and its associated mortality in patients with or without diabetes mellitus (DM, non-DM), which will enable development of prospective strategies that will capture hypoglycemia promptly and provide an integrated approach for prevention of such episodes. Methods: We retrieved all ambulance calls activated for hypoglycemia in Olmsted County, Minnesota, between January 1, 2003 and December 31, 2009. Results: A total of 1473 calls were made by 914 people (DM 8%, non-DM 16%, unknown DM status 3%). Mean age was 60 ± 16 years with 49% being female. A higher percentage of calls were made by DM patients (87%) with proportionally fewer calls coming from non-DM patients (11%) (chi-square test, p < .001), and the remaining 2% calls by people with unknown DM status. Emergency room transportation and hospitalization were significantly higher in non-DM patients compared to DM patients ( p < .001) and type 2 diabetes mellitus compared to type 1 diabetes mellitus ( p < .001). Sulphonylureas alone or in combination with insulin varied during the study period ( p = .01). The change in incidence of EMS for hypoglycemia was tracked during this period. However, causality has not been established. Death occurred in 240 people, 1.2 (interquartile range 0.2–2.7) years after their first event. After adjusting for age, mortality was higher in non-DM patients compared with DM patients ( p < .001) but was not different between the two types of DM. Conclusions: The population burden of EMS requiring hypoglycemia is high in both DM and non-DM patients, and imposes significant burden on medical resources. It is associated with long-term mortality.
Geoenvironmental Diabetology
Wellik, Kay E., Fowke, Margaret, Cook, Curtiss B.

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 5 | Issue: 4 | Pages: 834-842

10.1177/193229681100500402 | PMID 21880222 Get It

Many reports have documented the negative health consequences that environmental stressors can have on patients with diabetes. Studies examining the interaction between the environment and a patient with diabetes can be unified under a single discipline termed “geoenvironmental diabetology.” Geoenvironmental diabetology is defined more specifically as the study of how geophysical phenomena impact a patient with diabetes, to include effects on metabolic control, ancillary equipment (e.g., glucometers and insulin pumps), medications, supplies, access to care, and influences on the adaptive strategies employed by patients to care for their diabetes under extreme circumstances. Geological events such as natural disasters (e.g., earthquakes) or extreme weather (e.g., heat waves) are examples of stressors that can affect patients with diabetes and that can be included under the heading of geoenvironmental diabetology. As proposed here, geoenvironmental diabetology refers to how events in the physical world affect those with diagnosed diabetes, rather than how environmental factors might trigger development of disease. As the global prevalence of diabetes continues to increase, including in parts of the world that are especially vulnerable to disasters and climate change, further discussion is warranted on how to best prepare for management of diabetes under conditions of extreme geological and weather events and a changing climate. An overview is presented of various studies that have detailed how geoenvironmental phenomena can adversely affect patients with diabetes and concludes with a discussion of requirements for developing strategies for geoenvironmental diabetes management.
Diabetes in the Desert: What Do Patients Know about the Heat?
Nassar, Adrienne A., Childs, Raymond D., Boyle, Mary E., Jameson, Kimberly A. , Fowke, Margaret, Waters, Ken R., Hovan, Michael J., Cook, Curtiss B.

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 4 | Issue: 5 | Pages: 1156-1163

10.1177/193229681000400514 | PMID 20920435 Get It

Background: This study aims to identify self-management strategies used by patients with diabetes in hot weather, examine knowledge of safe temperatures and exposure times, and evaluate comprehension of weather data. Methods: Patients attending an endocrinology clinic in southwestern United States were surveyed. Results: One hundred fifty-two surveys completed from November 30 to December 31, 2009 were analyzed. Mean patient age was 64 years; diabetes duration, 15 years; 51% were women, 83% had type 2 diabetes, 58% were non Hispanic white, and 77% were on insulin injections. Mean hemoglobin A1c was 7.9%; 38% had hemoglobin A1c values of 8.0% or higher. Patients used an array of personal protective measures during hot weather, and 71% limited heat exposure to less than one hour. Respondents typically took steps to protect their diabetes medication and supplies, but 37% chose to leave medications and supplies at home. Although 73% of respondents had received information regarding the effect of heat on insulin, only 39% had received information about the effect of heat on oral medications, 41% on glucose meters, and 38% on glucose test strips. The temperature at which patients took protective measures varied. Only 55% knew the definition of the heat index. Conclusion: Most survey participants took measures to protect themselves from the heat, although gaps in knowledge were evident. Many patients had suboptimal glycemic control, placing them potentially at risk for dehydration during the hottest months. Increased public awareness of this topic is needed, and diabetes education programs should include information about the heat where appropriate.